tiprankstipranks
Trending News
More News >
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Hong Kong Market

Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Revenue

Compare
4 Followers

Shanghai Junshi Biosciences Co., Ltd. Class H Revenue

Shanghai Junshi Biosciences Co., Ltd. Class H had a revenue of 677.12M in the quarter ending Dec 31, 2024, with 39.57%. This bring the company's revenue in the last twelve months to 1.95B, Decreased 9.01%. In the fiscal year ending Dec 31, 2024, Shanghai Junshi Biosciences Co., Ltd. Class H had annual revenue of 1.95B with 29.67% growth.
Revenue (ttm)
1.95B
Revenue Growth
25.96%
P/S Ratio
17.34
Revenue/Employee
HK$755,748
Employees
2,578
Market Cap
HK$33.78B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.95B445.77M+29.67%
Dec 31, 2023
1.50B49.06M+3.38%
Dec 31, 2022
1.45B-2.57B-63.89%
Dec 31, 2021
4.02B2.43B+152.36%
Dec 31, 2020
1.59B819.81M+105.77%
Dec 31, 2019
775.09M774.15M+82,885.97%
Dec 31, 2018
934.00K-214.00K-18.64%
Dec 31, 2017
1.15M-2.61M-69.44%
Dec 31, 2016
3.76M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis